HCG Aastha Cancer Centre, Sola, Ahmedabad

Lung and Thoracic Cancer Surgery involves the surgical removal of tumours from the lungs, chest wall, or the mediastinum (the space between the lungs). The primary goal is to achieve an "R0 resection," meaning the entire tumour is removed with clear, cancer-free margins. Clinical standards favor minimally invasive approaches like VATS and RATS to preserve respiratory function and accelerate recovery.

• Early-Stage NSCLC: For Non-Small Cell Lung Cancer (Stage I or II) where surgery offers the highest chance of a permanent cure.

• Solitary Pulmonary Nodules: When a suspicious "spot" on the lung is growing or has high-risk features on a PET-CT.

• Mediastinal Tumours: Malignancies located in the center of the chest, such as thymomas or germ cell tumours.

• Metastatic "Oligometastases": When cancer from another organ (like the kidney or colon) has spread only to a limited area of the lung.

• Chest Wall Involvement: When a lung tumour has invaded the ribs, requiring a combined resection and reconstruction.

• Wedge Resection: Removal of a small, pie-shaped piece of lung; reserved for very small peripheral tumours or patients with limited lung capacity.

• Segmentectomy: Removal of a specific functional segment. This 2026 standard preserves more healthy tissue than a lobectomy for early-stage "ground-glass" opacities.

• Lobectomy: The "gold standard" for most lung cancers. One of the five lobes (three right, two left) is removed entirely to capture all local lymph drainage.

• Pneumonectomy: Removal of an entire lung; only performed for centrally located tumours involving the main bronchus.

• Sleeve Resection: A lung-sparing alternative to pneumonectomy where a section of the bronchus is removed and the healthy ends are sewn back together.

• RATS (Robotic-Assisted Thoracic Surgery): The 2026 preferred method for complex dissections. It provides 3D visualization and extreme precision for removing lymph nodes in the narrow mediastinum.

• VATS (Video-Assisted Thoracoscopic Surgery): A minimally invasive approach using 2–3 small incisions (1–3 cm). It results in significantly less pain and faster return to activity.

• Thoracotomy (Open Surgery): A larger incision on the side of the chest where ribs are spread; necessary for very large tumours or those involving major heart vessels.

• Mediastinoscopy: A small incision at the base of the neck used to biopsy lymph nodes and confirm the cancer hasn't spread before a major resection.

• Pleurodesis: A procedure for fluid buildup (effusion) where a sterile agent is used to make the lung stick to the chest wall, preventing fluid return.

• Anaesthesia: Performed under general anaesthesia, typically using a "double-lumen" tube to deflate the lung being operated on.

• Nodal Staging: Regardless of resection type, surgeons perform a mandatory lymphadenectomy to check for microscopic spread.

• Airlock Testing: Before closing, the lung is reinflated under water to check for bubbles, ensuring the surgical site is airtight.

• Chest Tube Placement: One or two tubes are placed in the pleural space to drain air and fluid, allowing the lung to remain fully expanded during healing.

• Pathologic Staging: The removed tissue is analyzed to determine if "adjuvant" chemotherapy or immunotherapy is needed post-surgery.

• PFT/Spirometry: Completing a Pulmonary Function Test to ensure the remaining lung tissue can support your breathing needs after surgery.

• Smoking Cessation: Adhering to a strict "zero-tobacco" policy for at least 4 weeks prior to surgery to reduce the risk of post-operative pneumonia.

• Incentive Spirometry: Training with a breathing exercise device to strengthen respiratory muscles before the procedure.

• Cardiac Risk Stratification: Undergoing an EKG or Echo to ensure the heart can handle the circulatory changes of thoracic surgery.

• Nutritional Optimization: A high-protein diet to ensure the pleura (lung lining) heals quickly and prevents prolonged air leaks.

• High-Resolution CT (Chest): To map the tumour's exact location in relation to the pulmonary arteries and veins.

• PET-CT Scan: To rule out any metabolic activity in other parts of the body, ensuring the surgery remains a curative option.

• Quantitative V/Q Scan: In borderline cases, this determines exactly how much "work" each lobe of your lung is doing.

• EBUS (Endobronchial Ultrasound): A specialized internal ultrasound used to biopsy lymph nodes near the windpipe before the main surgery.

• Liquid Biopsy: 2026 protocols may include a blood test to check for circulating tumour DNA (ctDNA) as a baseline for recovery.

• Chest Tube Management: Tubes are usually removed within 2–4 days once the "air leak" has stopped and drainage is minimal.

• AFib Monitoring: Irregular heart rhythms occur in 10–20% of patients due to inflammation near the heart; this is typically temporary.

• Early Mobilization: You will be encouraged to sit up and walk within 24 hours to prevent blood clots and help the lung expand.

• Subcutaneous Emphysema: A "crackling" sensation under the skin if air traps there; it is harmless and usually resolves on its own.

• Long-Term Breathlessness: Most patients return to normal activity in 4–8 weeks, though heavy aerobic exercise may feel different depending on the amount of lung removed.

• Robotic Precision: RATS allows for more thorough lymph node removal than traditional surgery, leading to more accurate staging and treatment.

• Lung-Sparing Techniques: 2026 advancements in segmentectomy and sleeve resections allow for cancer removal while saving as much healthy lung as possible.

• Enhanced Recovery (ERAS): Specialized thoracic protocols significantly reduce the need for heavy narcotics, allowing for faster mental and physical recovery.

• Curative Foundation: Surgery remains the single most effective way to eliminate early-stage lung cancer and prevent future spread.

A pneumonectomy is the surgical removal of an entire lung. It is a major thoracic operation reserved for cases where a tumor is so centrally located or extensive that removing only a portion of the lung (like a lobectomy) would leave cancer cells behind. While it significantly impacts breathing capacity, many patients successfully adapt to living with one healthy lung through specialized pulmonary rehabilitation.

• Central Tumors: When the cancer is located in the main bronchus (airway) or involves the main pulmonary artery or vein.

• Multi-Lobar Involvement: When the tumor crosses the anatomical fissures and involves all lobes of a single lung.

• Locally Advanced NSCLC: For Stage II or III Non-Small Cell Lung Cancer that cannot be cleared by a "sleeve" resection.

• Malignant Mesothelioma: An Extrapleural Pneumonectomy may be performed to remove the lung, the lining (pleura), part of the diaphragm, and the heart sac (pericardium).

• Recurrent Cancer: When cancer returns in a lung that has previously undergone a partial removal (Completion Pneumonectomy).

• Traditional Pneumonectomy: Removal of the entire left or right lung.

• Extrapleural Pneumonectomy (EPP): A radical version often used for mesothelioma, removing the lung along with surrounding membranes and a portion of the diaphragm.

• Completion Pneumonectomy: The removal of the remaining part of a lung after a previous surgery has already been performed.

• Carinal Pneumonectomy: A highly complex procedure where the lung is removed along with the "fork" of the windpipe (carina), followed by reconstruction of the airway.

• One-Lung Ventilation: Performed under general anesthesia using a special tube that allows the surgeon to deflate the lung being removed while the other lung is safely ventilated.

• Thoracotomy Access: Usually requires an incision around the side to the back (posterolateral thoracotomy) to provide the best view of the major heart and lung vessels.

• Vascular Ligation: The main pulmonary artery and pulmonary veins are carefully tied off and divided using surgical staplers.

• Bronchial Stump Closure: The main airway is cut close to the windpipe and sealed. Surgeons often reinforce this "stump" with a flap of nearby tissue to prevent air leaks.

• The "Empty" Cavity: Unlike other lung surgeries, a chest tube is often not used for suction afterward. The empty space naturally fills with fluid over time, which eventually turns into a gel-like substance to prevent the heart from shifting too far.

• Extensive PFTs: Comprehensive Pulmonary Function Tests to calculate exactly how much breathing capacity you will have left with just one lung.

• Cardiac Stress Testing: Because removing a lung puts extra pressure on the heart, an Echocardiogram or Stress Test is mandatory to ensure the heart is strong enough.

• Nutritional Optimization: A high-protein, calorie-dense diet is started weeks before to ensure the body can handle the significant healing required.

• Pre-habilitation: Specialized exercises to strengthen the "good" lung and the muscles used for breathing before the surgery begins.

• Smoking Cessation: Total cessation is required at least 4–8 weeks prior to reduce the high risk of post-operative pneumonia.

• PET-CT and Brain MRI: To confirm that the cancer has not spread outside of the lung being removed.

• EBUS / Mediastinoscopy: Biopsies of the lymph nodes in the center of the chest to ensure the cancer is still "resectable."

• V/Q Scan: A quantitative Ventilation/Perfusion scan to determine the percentage of lung function contributed by each lung.

• Baseline ABG: An Arterial Blood Gas test to measure the current oxygen and carbon dioxide levels in your blood.

• Blood Type & Cross-match: Due to the risk of bleeding from major vessels, blood is held in reserve for the procedure.

• ICU Stay: Most patients spend the first 24–48 hours in the Surgical Intensive Care Unit for close monitoring of heart rhythm and oxygen levels.

• Hospital Timeline: Expect a stay of 7 to 10 days. Recovery at home typically takes 2 to 4 months.

• Atrial Fibrillation (AFib): Common (up to 30%) as the heart adjusts to new pressures in the chest; it is usually temporary and managed with medication.

• Shortness of Breath: You will likely feel breathless with heavy exertion, but most patients can perform daily activities without supplemental oxygen.

• Post-Pneumonectomy Syndrome: A rare late complication where the heart shifts too far into the empty space; modern techniques use tissue flaps or fillers to prevent this.

• Definitive Local Control: It is the most aggressive way to ensure a "clean margin" when a tumor is large or centrally located.

• Lung Adaptation: The remaining lung undergoes "compensatory hyperinflation," expanding slightly and becoming more efficient at gas exchange over time.

• Integrated 2026 Care: Combined with modern neoadjuvant immunotherapy, a pneumonectomy can provide long-term survival for cases previously considered inoperable.

• Pulmonary Rehab: Supervised rehabilitation programs significantly improve "one-lung" quality of life, helping patients return to travel and hobbies.

Mediastinal Lymph Node Dissection (MLND) is a surgical procedure to remove the lymph nodes located in the mediastinum—the central area of the chest between the lungs. It is a critical component of lung cancer surgery. Rather than just taking a sample, the surgeon removes all the lymph nodes and surrounding fat within specific "stations" to ensure any microscopic cancer spread is captured. This procedure is the gold standard for accurate pathologic staging, which dictates whether a patient needs further treatment like immunotherapy or chemotherapy.

• Lung Cancer Surgery: Performed as a mandatory part of a lobectomy or pneumonectomy for Non-Small Cell Lung Cancer (NSCLC).

• Staging Accuracy: When imaging (PET-CT) suggests nodes might be involved, or even if they look normal but the primary tumor is large.

• Thymic Tumors: For patients with thymoma or thymic carcinoma to check for regional spread.

• Esophageal Cancer: Often included in an esophagectomy to clear the lymphatic drainage path of the esophagus.

• Diagnostic Uncertainty: When non-surgical biopsies (like EBUS) are inconclusive but suspicion of nodal involvement remains high.

• Robotic-Assisted (RATS) Dissection: The preferred modern tool for MLND. Its 3D magnification allows surgeons to see tiny nerves and vessels clearly, making it safer to remove nodes deep in the chest.

• Video-Assisted Thoracoscopic (VATS) Dissection: A minimally invasive approach using a camera and specialized instruments through small "keyhole" incisions.

• Open Thoracotomy Dissection: Usually performed through the same large incision used for an open lung resection, allowing for direct manual access to the mediastinum.

• Mediastinoscopy: A separate, smaller surgical procedure where a scope is inserted through a small notch at the base of the neck to reach the upper nodal stations.

• Systematic Nodal Sampling: A less extensive version where only representative nodes are taken, though full dissection (MLND) is preferred for more accurate staging.

• Surgical Access: The surgeon enters the chest cavity using the same approach selected for the primary lung or esophageal resection.

• Anatomical Exposure: The surgeon opens the thin lining (pleura) over the mediastinum to expose the fat pads containing the lymph nodes near the trachea, esophagus, and heart.

• Systematic Clearance: All lymphoid tissue and surrounding fat within the targeted "stations" are meticulously removed.

• Nerve Preservation: Great care is taken to identify and protect the Phrenic nerve (for breathing) and the Recurrent Laryngeal nerve (for the voice) that run through the mediastinum.

• Hemostasis: Using advanced energy devices like ultrasonic scalpels, the surgeon seals small lymphatic channels and blood vessels to prevent fluid buildup or "oozing."

• Pathology Review: The removed nodes are labeled by their specific station number and sent to a lab where a pathologist examines them under a microscope for cancer cells.

• PET-CT Scan: To identify which nodal stations show "metabolic activity," helping the surgeon prioritize specific areas for thorough dissection.

• EBUS-TBNA: Many patients undergo an Endobronchial Ultrasound biopsy before surgery to "pre-stage" the nodes and plan the extent of the dissection.

• Cardiovascular Review: Since the surgery occurs near the heart and great vessels, ensuring stable heart function is vital for a safe procedure.

• Anticoagulation Management: Stopping blood thinners is critical, as MLND involves working around highly vascular structures where bleeding must be strictly controlled.

• Incentive Spirometry: Strengthening the lungs before the procedure to ensure you can cough effectively and clear your airway post-operatively.

• High-Resolution Chest CT: To map the anatomy of the lymph nodes in relation to the laryngeal nerve and the superior vena cava.

• Endobronchial Ultrasound (EBUS): To provide a preliminary assessment of the nodes through the airway before the definitive surgical removal.

• Chest MRI: Sometimes used if nodes are near the spine or major nerves to evaluate if the tumor has invaded those structures.

• Blood Coagulation Profile: To ensure the body can effectively stop minor oozing from the lymphatic channels after the nodes are removed.

• Baseline Vocal Assessment: Since nerves controlling the voice box are located in the mediastinum, a baseline check of the voice is often performed for comparison after surgery.

• Chest Tube Management: You will have a chest tube for a few days to drain any fluid or air; it is removed once the drainage levels from the dissection site are safe.

• Vocal Cord Monitoring: A temporary hoarse voice can occur if the laryngeal nerve is irritated during the dissection; most cases recover with time and specialized therapy.

• Dietary Adjustments: In rare cases of "Chylothorax" (lymphatic fluid leak), a specific low-fat diet may be required for a short period to allow the duct to heal.

• Pain Management: Dissection near the ribs and spine can cause localized "aching" or soreness; this is managed with nerve blocks and oral medications.

• Follow-up Treatment: The final "nodal status" (Pathology Report) typically takes 5–7 days and is the most important factor in determining if you need follow-up chemotherapy or immunotherapy.

• Definitive Staging: MLND provides the most accurate "N" (Nodal) stage, which is far more precise than a PET-CT or EBUS biopsy alone.

• Reduced Recurrence: Removing all nodes in a station (rather than just sampling) significantly lowers the chance of the cancer returning in the center of the chest.

• Adjuvant Guidance: Knowing exactly which nodes are involved allows oncologists to prescribe targeted therapies or immunotherapies that can significantly improve survival rates.

• Minimal Impact on Recovery: When performed robotically or thoracoscopically, adding MLND to a lung resection adds very little time to the hospital stay but provides invaluable data.

• Comprehensive Clearance: Ensures that any microscopic clusters of cancer cells in the regional lymph system are physically removed from the body.

A Lobectomy is the surgical removal of an entire lobe of the lung. Since the right lung has three lobes and the left lung has two, this procedure removes a significant portion of lung tissue to treat localized conditions, most commonly Non-Small Cell Lung Cancer (NSCLC). By removing the affected lobe, surgeons aim to eliminate the primary tumor and prevent the spread of disease to the rest of the respiratory system.

• Early-Stage Lung Cancer: It is the "gold standard" treatment for Stage I and Stage II Non-Small Cell Lung Cancer where the tumor is confined to a single lobe.

• Tuberculosis (TB): In rare cases where a localized infection has caused extensive lung damage that does not respond to antibiotic therapy.

• Bronchiectasis: When a portion of the lung's airways is permanently damaged and widened, leading to chronic infections and coughing up blood.

• Fungal Infections: For localized fungal masses (aspergillomas) that carry a high risk of causing life-threatening bleeding.

• Benign Tumors: Large non-cancerous growths that compress healthy lung tissue or interfere with normal breathing patterns.

• Thoracotomy (Open Surgery): A traditional approach where a 6-to-10-inch incision is made on the side of the chest and the ribs are spread to provide direct access to the lung.

• VATS (Video-Assisted Thoracoscopic Surgery): A minimally invasive method using 2–3 small "keyhole" incisions, a camera, and specialized long-handled instruments.

• Robotic-Assisted Lobectomy: A variation of the minimally invasive approach that uses robotic arms controlled by the surgeon for higher precision in tight spaces.

• Sleeve Lobectomy: A complex technique where a lobe is removed and the remaining parts of the airway are reconnected, often used to preserve more lung function.

• Segmentectomy: Removing only a small segment of a lobe; occasionally considered if the patient's overall lung function is too weak for a full lobectomy.

• Double-Lumen Intubation: Under general anesthesia, a special breathing tube is used to deflate the lung being operated on while the other lung continues to provide oxygen.

• Access and Visualization: Depending on the chosen method, the surgeon enters the chest cavity and identifies the lobe containing the tumor or diseased tissue.

• Vessel Dissection: The surgeon carefully identifies, clamps, and seals the three main structures connected to the lobe: the pulmonary artery, the pulmonary vein, and the bronchus (airway).

• Lobe Removal: Once the blood supply and airway are disconnected, the diseased lobe is placed in a surgical bag and removed from the chest.

• Lymph Node Dissection: Nearby lymph nodes are removed and tested to determine if the cancer has spread beyond the primary site.

• Chest Tube Placement: A plastic tube is inserted through the chest wall to drain air, blood, and fluid, allowing the remaining lung tissue to re-expand and fill the space.

• Pulmonary Function Test (PFT): A mandatory test to measure lung capacity and ensure the remaining lung tissue can support healthy breathing after surgery.

• PET/CT Scan: High-resolution imaging used to confirm the cancer is localized and has not spread to other organs or distant lymph nodes.

• Smoking Cessation: Patients must stop smoking at least 4 weeks prior to surgery to significantly reduce the risk of postoperative pneumonia and poor wound healing.

• Cardiac Clearance: An EKG or stress test may be required to ensure the heart is strong enough to handle the physiological stress of lung surgery.

• Fasting (NPO): No food or drink for 8–12 hours prior to the procedure to ensure safety under general anesthesia.

• CT Angiography: To provide a detailed map of the pulmonary blood vessels and the tumor’s exact location relative to the heart.

• Bronchoscopy: A thin camera is passed down the airway to inspect the bronchial tubes and confirm the tumor's boundaries.

• Quantitative V/Q Scan: Occasionally used to predict exactly how much lung function will remain after the specific lobe is removed.

• Blood Panels: Routine screens to check oxygen levels, kidney function, and blood clotting ability.

• Hospital Stay: Typically 3 to 7 days; patients who undergo minimally invasive VATS or robotic surgery often recover and return home sooner.

• Respiratory Therapy: Patients must use an incentive spirometer every hour and perform deep coughing exercises to keep the remaining lung clear of mucus.

• Pain Management: Significant chest wall pain is expected; an epidural or specialized pain pump is often used for the first 48 hours to manage discomfort.

• Early Mobilization: Walking is required within 24 hours of surgery to improve circulation and prevent blood clots in the legs (DVT).

• Activity Resumption: Most patients return to normal daily activities within 6 to 12 weeks, though they may feel winded during heavy exercise for several months.

• High Curative Potential: For early-stage lung cancer, removing the entire lobe offers the best chance for a long-term cure and cancer-free survival.

• Prevents Spread: By removing the primary tumor and the associated lymph nodes, the surgery halts the progression of the disease to other parts of the body.

• Diagnostic Certainty: Provides a large tissue sample for the pathology team to precisely stage the cancer and determine if further treatment is needed.

• Improved Respiratory Health: In cases of chronic infection or bronchiectasis, removing the damaged lobe eliminates a constant source of illness and inflammation.

• Long-Term Durability: For most patients, the remaining lung tissue expands and adapts, allowing for a healthy and active lifestyle after recovery.

Head and Neck Cancer Treatment encompasses a range of specialized medical and surgical interventions designed to eliminate malignant tumors in the mouth, throat, voice box, and nasal passages. Clinical protocols prioritize the preservation of speech and swallowing functions through a multimodal approach, integrating precision surgery with advanced immunotherapy to address squamous cell carcinomas effectively.

• Persistent Sores: Appearance of a sore, ulcer, or red and white patches in the mouth that do not heal within two weeks.

• Throat Discomfort: A persistent sore throat or a constant feeling that something is caught in the back of the throat.

• Voice Changes: Noticeable hoarseness or a significant change in the quality or pitch of the voice.

• Dysphagia: Difficulty or pain experienced during the process of swallowing food or liquids.

• New Growths: Discovery of a new lump, swelling, or painless mass in the neck, jaw, or facial area.

• Nasal/Ear Symptoms: Frequent nosebleeds, persistent nasal congestion, or chronic ear pain without an active infection.

• Oral Cavity Cancers: Malignancies affecting the lips, tongue, gums, or the mucosal lining of the cheeks.

• Oropharyngeal Cancers: Particularly those linked to the HPV-16 virus, often located in the tonsils or the base of the tongue.

• Laryngeal Malignancies: Cancers occurring in the tissues of the voice box that impact breathing and speech.

• Sinonasal Tumors: Rare tumors in the nasopharynx or paranasal sinuses requiring complex anatomical access.

• Recurrent/Metastatic HNSCC: Squamous cell carcinomas that have returned or spread to distant organs like the lungs.

• Transoral Robotic Surgery (TORS): A minimally invasive technique used to remove throat tumors through the mouth, avoiding large external incisions.

• Neck Dissection: The surgical removal of lymph nodes in the neck to prevent or treat the regional spread of cancer.

• Immunotherapy: Checkpoint inhibitors (such as Pembrolizumab or Nivolumab) are now standard first-line treatments for advanced disease.

• Targeted Therapy: Precision medications like Cetuximab that block specific proteins facilitating cancer cell growth.

• Intensity-Modulated Radiation Therapy (IMRT): High-precision radiation that conforms to the tumor's 3D shape to spare the salivary glands.

• Photodynamic Therapy: A treatment using light-sensitive drugs and laser energy to destroy superficial mucosal cancers.

• Diagnostic Mapping: High-resolution CT, MRI, and PET scans are utilized to create a precise map of the tumor and nearby nerves.

• Histology Confirmation: A tissue biopsy is conducted to confirm the presence of squamous cell carcinoma and check for HPV status.

• Precision Surgery: Surgeons remove the primary tumor, often using robotic tools to navigate the narrow passages of the throat.

• Adjuvant Radiation: Precision radiation is applied to the mucosal lining to destroy any microscopic cells remaining after surgery.

• Immune Priming: Immunotherapy infusions help the body's T-cells identify and destroy cancer cells throughout the system.

• Functional Rehab: Specialized sessions are integrated early to support the recovery of speech, airway protection, and swallowing.

• Baseline Therapy: Consult with a speech and swallow therapist to establish a functional baseline for post-operative recovery.

• Dental Clearance: Undergo a comprehensive dental evaluation, as radiation can significantly impact jawbone health and density.

• Cessation Programs: Adhere to strict smoking and alcohol cessation programs, as continued use significantly lowers treatment success.

• Nutritional Mapping: Follow specific high-calorie nutritional guidelines to maintain strength and prevent weight loss during therapy.

• Surgical Roadmarking: Complete all diagnostic mapping to ensure the surgical team has a clear view of critical tumor margins.

• Fiberoptic Endoscopy: A visual inspection using a thin, flexible tube to examine the throat, larynx, and nasal passages.

• Head and Neck MRI: To determine the exact size and depth of the malignancy and its proximity to major blood vessels.

• PET-CT Scan: To evaluate metabolic activity and check if the cancer has spread to the chest or distant lymph nodes.

• HPV Biomarker Testing: Specifically testing for p16 protein to identify viral status, which dictates the intensity of the treatment.

• Immune Profiling: Comprehensive blood panels to assess PD-L1 levels, helping to predict responsiveness to immunotherapy.

• Surveillance Schedule: Regular physical exams and imaging every 3 months for the first two years to monitor for early signs of recurrence.

• Oral Health Vigilance: Commitment to lifelong dental hygiene and fluoride treatments to manage the long-term effects of radiation on saliva.

• Lifestyle Maintenance: Absolute avoidance of tobacco and alcohol to prevent the development of a second primary cancer.

• Functional Maintenance: Continued participation in speech therapy and swallowing exercises to prevent long-term joint stiffness (trismus).

• Mucosal Monitoring: Routine follow-up appointments with a specialist to ensure the continued health of the mucosal surfaces.

• Superior Survival Rates: Features high survival rates for localized cases through early detection and robotic surgery.

• Revolutionary Immunotherapy: Modern standards use neoadjuvant (pre-surgery) immunotherapy to shrink tumors and improve surgical outcomes.

• Aesthetic Preservation: Employs robotic technology and reconstructive microsurgery to minimize physical changes and preserve facial appearance.

• Organ Preservation: Prioritizes de-escalated protocols for HPV-positive cases to preserve vital functions like speaking and eating.

• Biologically Tailored Care: Every plan is customized based on the tumor's genetic signature and viral status for maximum impact.

Thyroid cancer treatment is highly successful, with a cure rate exceeding 90% for the most common types. Unlike many other cancers, it often relies on a combination of surgery and radioactive isotopes rather than traditional chemotherapy. Modern protocols are increasingly conservative, with "active surveillance" or partial surgery being used for small, low-risk tumors to preserve natural hormone function.

• Painless Lump: A noticeable nodule or swelling in the front of the neck, often near the Adam's apple.

• Voice Changes: Increasing hoarseness or breathiness that does not resolve within a few weeks.

• Dysphagia: Difficulty swallowing or a persistent "lump in the throat" sensation.

• Persistent Cough: A chronic cough that is not caused by a cold or respiratory infection.

• Neck Pain: Pain that starts in the front of the neck and sometimes radiates up toward the ears.

• Family History: If you have a known genetic predisposition, such as the RET gene mutation (common in Medullary Thyroid Cancer).

• Hemithyroidectomy (Lobectomy): Removal of only one of the two thyroid lobes. This is a common preference for small, low-risk tumors to avoid lifelong medication.

• Total Thyroidectomy: Removal of the entire gland; the standard for larger tumors or high-risk variants like Papillary or Follicular cancer.

• Neck Dissection: If the cancer has reached the lymph nodes, the surgeon removes them during the same operation to prevent further spread.

• Robotic/Endoscopic Thyroidectomy: Minimally invasive techniques that can sometimes be performed through the armpit or mouth to avoid a visible neck scar.

• Targeted Internal Radiation: Used after surgery to destroy any remaining microscopic thyroid cells or cancer that has spread elsewhere.

• How it Works: Since thyroid cells specifically absorb iodine, patients swallow a pill (I-131) that kills those cells specifically, sparing the rest of the body.

• Preparation: Patients follow a low-iodine diet for 1–2 weeks and receive Thyrogen injections to make any remaining cancer cells "hungry" for the radioactive dose.

• Isolation Protocols: Because you temporarily become a radiation source, you must follow strict isolation (usually 3–5 days) to protect family members and pets.

• Diagnostic Mapping: Ultrasound and Fine Needle Aspiration (FNA) are used to confirm the cancer type and map the tumor's size.

• Anesthesia: Surgery is performed under general anesthesia, typically lasting 2 to 4 hours.

• Nerve Monitoring: Surgeons use specialized equipment to monitor the laryngeal nerves during surgery to protect your voice.

• Hormone Replacement: Following a total thyroidectomy, you will start a daily dose of Levothyroxine (T4) to replace the missing hormones.

• Suppression Therapy: Doctors prescribe a hormone dose to keep TSH (Thyroid Stimulating Hormone) levels very low, which helps prevent any dormant cancer cells from being stimulated to grow.

• Voice Assessment: A baseline check of your vocal cord function is often conducted by an ENT specialist.

• Calcium Management: Your surgeon may check your parathyroid function, as these tiny glands (which control calcium) sit right behind the thyroid.

• Medication Review: Stopping any blood thinners or supplements that could increase bleeding risk during the neck surgery.

• Fasting (NPO): Standard instructions starting at midnight before the operation to ensure safety during anesthesia.

• Low-Iodine Planning: If RAI is scheduled, start familiarizing yourself with iodine-free recipes (avoiding iodized salt, dairy, and seafood).

• Neck Ultrasound: The primary tool for determining the exact size of the tumor and whether lymph nodes look suspicious.

• Fine Needle Aspiration (FNA): A biopsy where a thin needle collects cells to determine if the tumor is Papillary, Follicular, or Medullary.

• Thyroid Function Tests (TFTs): Blood tests to measure T3, T4, and TSH levels before the gland is altered.

• CT/MRI Scan: Occasionally used for advanced cases to see if the tumor is invading the esophagus or windpipe.

• Molecular Testing: Biopsies are often sent for mutation testing (like BRAF or TERT) to predict how aggressive the cancer might be.

• Lifelong Medication: If the entire thyroid was removed, you will take a small pill every morning on an empty stomach for the rest of your life.

• Tumor Marker (Tg) Monitoring: You will have regular Thyroglobulin (Tg) blood tests. Since only thyroid tissue makes this protein, a rising level acts as an early warning system.

• Periodic Scans: Neck ultrasounds every 6–12 months to ensure the "bed" of the thyroid remains clear of any recurrence.

• Calcium Supplements: Some patients may need temporary calcium and Vitamin D if the parathyroid glands were "stunned" during surgery.

• Energy Management: It can take a few months to find your perfect hormone dose; communicate any fatigue or heart palpitations to your doctor.

• Exceptionally High Cure Rate: Most common thyroid cancers have a 10-year survival rate near 95–98%.

• Targeted Radiation: RAI therapy provides a way to treat metastatic disease with much less toxicity than standard chemotherapy.

• Preservation of Function: Current protocols allow many patients to keep half their thyroid, potentially avoiding the need for lifelong medication.

• Minimal Disruption: Most patients return to work and normal activity within 2 weeks of surgery.

• Precision Monitoring: The Thyroglobulin test provides one of the most accurate early detection systems in all of oncology.

Oral Cancer Surgery (also known as head and neck surgery) is the primary treatment for cancers of the lips, tongue, inner cheeks, gums, and the floor or roof of the mouth. The goal is to remove the entire tumor while preserving as much function (speaking and swallowing) and appearance as possible. Many of these procedures are integrated with microvascular reconstruction in a single session to ensure the best functional outcomes.

• Tongue Malignancy: When a biopsy confirms squamous cell carcinoma on the lateral borders or base of the tongue.

• Hard Palate or Gum Tumors: When cancer involves the roof of the mouth or the bony structures supporting the teeth.

• Lip Cancer: For lesions that do not respond to topical treatments or show signs of deep invasion.

• Floor of Mouth Lesions: When a tumor is located under the tongue, often requiring a "pull-through" resection.

• Buccal Mucosa Cancer: For malignancies on the inner lining of the cheeks that may involve the underlying muscle.

• Glossectomy: Removal of part or all of the tongue. A partial glossectomy removes only the cancerous edge, while a total glossectomy requires extensive reconstruction.

• Mandiblectomy: Removal of a portion of the jawbone. A "marginal" resection removes the bone surface, while a "segmental" resection removes a full section if the cancer has invaded the marrow.

• Maxillectomy: Removal of part or all of the hard palate (the roof of the mouth).

• Mohs Surgery: Often utilized for lip cancer; thin layers of tissue are removed and examined microscopically in real-time until no cancer cells remain.

• Wide Local Excision: Removing the tumor along with a 1-cm to 2-cm "clear margin" of healthy tissue to prevent local recurrence.

• Selective Neck Dissection: Removing only the lymph nodes in specific "levels" most likely to contain microscopic spread.

• Radical Neck Dissection: Removing nearly all lymph nodes on one side of the neck; reserved for advanced disease where cancer involves the surrounding muscle or veins.

• Sentinel Node Biopsy: Injecting a radioactive tracer or dye to identify and remove only the "first" node in the drainage path.

• Level-Specific Clearance: Surgeons use precise mapping to clear Level I, II, and III nodes, which are the primary sites for oral cancer metastasis.

• Free Flap Transfer: The "gold standard." Surgeons transfer tissue (skin, muscle, or bone) from the forearm or leg and sew the tiny blood vessels to the neck vessels using a microscope.

• Fibula Free Flap: Taking a piece of the lower leg bone to reconstruct a segment of the jawbone (mandible).

• Radial Forearm Free Flap: Using skin from the inner wrist to reconstruct the tongue or the floor of the mouth.

• Skin Grafts: Utilizing a thin layer of skin from the thigh to cover smaller defects within the oral cavity.

• Local Flaps: Rotating nearby tissue from the neck or forehead to fill gaps in the cheek or palate.

• Anesthesia: Performed under general anesthesia, often involving a specialized tube to keep the mouth clear for the surgeon.

• Tracheostomy: A temporary hole is made in the windpipe to ensure a safe airway while post-operative swelling subsides.

• Micro-dissection: Using high-powered magnification to identify and preserve the nerves responsible for tongue movement and facial expression.

• Feeding Tube Placement: A temporary tube is placed to provide nutrition while the oral tissues heal.

• Frozen Section Analysis: Real-time pathology checks during surgery to confirm that all margins are negative for cancer before the reconstruction begins.

• Dental Clearance: A thorough dental exam to remove any decayed teeth in the radiation field or surgical site.

• Speech and Swallow Baseline: Meeting with a therapist to evaluate your current function and plan for post-operative rehabilitation.

• Allen’s Test: If a forearm flap is planned, this test ensures the hand has adequate blood supply from other arteries.

• Nutritional Loading: High-protein supplementation to prevent weight loss, as eating will be difficult immediately following surgery.

• Imaging Correlation: Reviewing 3D reconstructions of CT or MRI scans to plan exact bone cuts for jaw reconstruction.

• CT/MRI Head and Neck: To determine the depth of invasion and whether the tumor is attached to the jawbone.

• PET-CT Scan: To rule out distant spread to the lungs or liver before committing to a major reconstructive surgery.

• Angiography/Doppler: To check the blood vessels in the "donor site" (arm or leg) to ensure they are healthy enough for a free flap.

• Panendoscopy: A visual inspection of the throat and esophagus under anesthesia to rule out a second primary tumor.

• Biopsy Confirmation: Confirming the histological type and grade of the cancer to determine the extent of neck dissection required.

• Hospital Stay: Typically 7 to 14 days, with the first few days often spent in an ICU or High Dependency Unit for flap monitoring.

• Flap Monitoring: A rare but serious risk where the blood supply to the new tissue fails, requiring an immediate return to the operating room.

• Fistula: An abnormal opening where saliva leaks from the mouth into the neck; usually managed with specialized dressings.

• Lymphedema: Swelling of the neck and face that may require specialized massage therapy after the lymph nodes are removed.

• Rehabilitation: Daily sessions with speech and language pathologists to relearn how to swallow safely and speak clearly.

• Functional Restoration: Modern microvascular surgery allows patients to maintain the ability to eat and speak even after extensive resections.

• High Cure Rates: For early-stage oral cancer, surgery offers a high probability of complete cure and long-term survival.

• 3D Precision: The use of surgical guides ensures that jaw reconstructions match the patient's original facial structure perfectly.

• Integrated Care: Combining surgery with adjuvant radiation ensures that any remaining microscopic cells are eliminated.

• Quality of Life: Dedicated head and neck teams focus on both removing cancer and the aesthetic and social reintegration of the patient.

Tongue Resection, clinically termed a glossectomy, is the surgical removal of all or part of the tongue to treat oral cancer. The primary goal is to excise the malignant tumor with a 1–2 cm "clear margin" of healthy tissue to prevent recurrence. Advanced microvascular reconstruction is now the standard for maintaining speech and swallowing functions after a resection.

• Squamous Cell Carcinoma (SCC): The most common form of tongue cancer, often appearing as a persistent ulcer or growth on the lateral (side) border.

• Deep Invasion: When a tumor has grown into the underlying intrinsic muscles of the tongue.

• Leukoplakia with Dysplasia: When precancerous white patches show high-grade changes that are likely to become invasive.

• Recurrent Disease: When cancer returns in a previously treated area of the mouth.

• Base of Tongue Tumors: When the malignancy is located at the very back of the tongue, near the throat.

• Partial Glossectomy: Removal of a small portion of the tongue. Usually, the remaining tissue is sewn together, and speech and swallowing remain near normal.

• Hemiglossectomy: Removal of one full side of the tongue. This typically requires reconstruction using tissue from another part of the body to maintain volume and mobility.

• Total Glossectomy: Removal of the entire tongue. This is a life-altering procedure reserved for advanced cancers and requires extensive microvascular reconstruction.

• Base of Tongue Resection: A specialized procedure for tumors at the back of the tongue, often performed robotically (TORS) to avoid large external incisions.

• Compartmental Resection: Removing the tumor along with the entire anatomical compartment of muscles to ensure no microscopic cells remain.

• Anesthesia: Performed under general anesthesia, often with a "nasotracheal" tube to provide the surgeon with a clear view of the oral cavity.

• Neck Dissection: A concurrent procedure where lymph nodes are removed from the neck to check for microscopic cancer spread.

• Resection with Margins: The surgeon uses specialized tools to cut 1–2 cm away from the visible tumor to ensure a "pathologically clear" margin.

• Microvascular Reconstruction (Free Flap): For larger defects, tissue (skin, fat, or muscle) is taken from the forearm or thigh, and its blood vessels are sewn to vessels in the neck using a microscope.

• Tracheostomy: A temporary breathing hole is made in the neck because postoperative swelling can block the airway; it is usually removed after 5–10 days.

• Feeding Tube Placement: Since the patient cannot swallow while the sutures heal, a temporary NG (nose-to-stomach) or PEG tube provides nutrition for 1–2 weeks.

• Speech and Swallow Baseline: Meeting with a specialist to assess current function and plan for intensive rehabilitation after surgery.

• Dental Evaluation: Removing any decayed teeth that might cause infection during healing or interfere with future radiation therapy.

• Allen’s Test: If a forearm flap is planned, this test ensures the hand has a sufficient secondary blood supply.

• Nutritional Optimization: Starting high-protein supplements to ensure the body has the resources to heal complex microvascular connections.

• Imaging Correlation: Reviewing 3D CT or MRI scans to map the tumor's depth and its proximity to the lingual artery and nerve.

• Contrast-Enhanced MRI: The "gold standard" for determining the exact depth of invasion (DOI) into the tongue muscle.

• PET-CT Scan: To rule out any spread to the lungs or distant lymph nodes before committing to a major reconstructive procedure.

• Biopsy Verification: Confirming the histological grade of the cancer to determine the necessary extent of the neck dissection.

• Doppler Ultrasound: To map the blood vessels in the donor site (arm or leg) to ensure they are suitable for a "free flap" transfer.

• Coagulation Profile: To ensure blood clots properly at the resection site but remains fluid enough for microscopic vascular connections.

• Hospital Stay: Typically 7 to 14 days, with the first few days spent in a specialized unit for frequent "flap checks" to ensure blood flow.

• Flap Failure: A rare but critical risk where the microscopic blood vessel connection clots, requiring immediate emergency re-operation.

• Aspiration Risk: If the new tongue cannot protect the airway during swallowing, food or saliva may enter the lungs, potentially causing pneumonia.

• Fistula: An abnormal leak of saliva from the mouth into the neck tissues, which usually requires specialized wound care to heal.

• Sensory Changes: Permanent numbness in the resected area or a loss of taste is common, though the other side of the tongue often compensates.

• Microvascular Precision: Modern "free flap" techniques allow surgeons to rebuild a tongue that can still move, speak, and push food to the back of the throat.

• Comprehensive Staging: Performing a neck dissection during the same surgery ensures that any microscopic spread is caught and treated early.

• Robotic (TORS) Advancements: For base-of-tongue cancers, robotic surgery allows for removal through the mouth, avoiding the need to "split" the jawbone.

• Intensive Rehabilitation: Standardized speech and swallow therapy significantly improves quality of life, helping patients return to a normal diet.

• Multidisciplinary Success: When surgery is followed by modern adjuvant radiation, local control rates for tongue cancer are at an all-time high.

Parotid Gland Surgery, or Parotidectomy, is the surgical removal of part or all of the parotid gland—the largest salivary gland, located just in front of the ear. When performed for cancer, the surgery is highly complex because the facial nerve, which controls all facial expressions (smiling, blinking, frowning), passes directly through the middle of the gland. The use of continuous intraoperative nerve monitoring is the standard of care to ensure the highest level of nerve preservation.

• Parotid Tumors: For any growth in the parotid gland, as about 20% of these are malignant (cancerous).

• Mucoepidermoid Carcinoma: The most common primary parotid cancer requiring surgical intervention.

• Adenoid Cystic Carcinoma: A slow-growing but aggressive cancer known for traveling along nerve fibers.

• Metastatic Skin Cancer: When skin cancer from the scalp or face spreads to the parotid lymph nodes.

• Recurrent Pleomorphic Adenoma: When a previously removed benign tumor returns, requiring a more extensive resection.

• Superficial Parotidectomy: Removal of the portion of the gland "outside" the facial nerve. This is the most common approach for tumors that have not invaded the deep lobe.

• Total Parotidectomy: Removal of the entire gland, including the deep lobe. The surgeon carefully "unfolds" the gland to peel it away from the facial nerve fibers.

• Radical Parotidectomy: Removal of the entire gland and the facial nerve. This is reserved for cases where the cancer has physically encased the nerve, causing paralysis before surgery.

• Extended Parotidectomy: Removal of the gland plus surrounding structures like the skin, ear canal, or jawbone if the cancer has spread beyond the gland boundaries.

• Enucleation/Extracapsular Dissection: A more limited removal used only for very small, superficial, and low-grade tumors.

• Anesthesia: Performed under general anesthesia. Surgeons avoid long-acting muscle relaxants to ensure the facial nerve can still be stimulated and monitored.

• The Incision: The incision usually starts in front of the ear and curves down into the neck (Blair or Face-lift incision), often hidden in natural skin creases.

• Facial Nerve Identification: The surgeon identifies the "trunk" of the facial nerve as it exits the skull and then meticulously follows its five branches.

• Nerve Monitoring: Small electrodes in the facial muscles alert the surgical team if the nerve is touched or stimulated, preventing accidental injury.

• Micro-dissection: Using high-power magnification or a microscope to separate the tumor from the delicate nerve fibers.

• Neck Dissection: If the cancer is high-grade, the surgeon removes lymph nodes in Levels I, II, and III of the neck during the same operation.

• Facial Nerve Baseline: A thorough examination of facial movements to document any pre-existing weakness caused by the tumor.

• Fine Needle Aspiration (FNA): A biopsy to determine the type and grade of the cancer, which helps plan the extent of the surgery.

• Dental Check: Ensuring there are no active oral infections that could complicate the surgical site.

• Tobacco Cessation: Stopping smoking at least 4 weeks prior to improve skin healing and reduce the risk of a salivary fistula.

• Medication Audit: Pausing any blood thinners or supplements that increase the risk of a hematoma (blood clot) under the facial skin.

• Contrast-Enhanced MRI: The preferred imaging to visualize the facial nerve's relationship to the tumor and check for spread along nerves.

• CT Scan: Useful for evaluating whether the cancer has invaded the nearby jawbone or the base of the skull.

• PET-CT Scan: Used for high-grade parotid cancers to rule out spread to the lungs or other distant sites.

• Ultrasound-Guided Biopsy: To obtain a tissue sample from the tumor or suspicious neck lymph nodes.

• Audiogram: Occasionally performed if the surgery involves the ear canal to establish a baseline for hearing.

• Hospital Stay: Usually 1 to 2 nights. A small plastic drain is often left in the neck for 24 hours to prevent fluid buildup.

• Facial Nerve Paresis: Temporary weakness of the face (e.g., a crooked smile or difficulty closing the eye) due to nerve manipulation. This usually resolves within 3–6 months.

• Frey’s Syndrome: A long-term complication where the cheek sweats or flushes while eating; treatments include Botox injections or specialized skin barriers.

• Numbness: Permanent numbness of the earlobe is common because a sensory nerve (greater auricular nerve) is often divided to reach the gland.

• Salivary Fistula: Saliva may leak from the remaining gland tissue under the skin, often managed with temporary pressure dressings.

• Nerve Preservation: Intraoperative monitoring has significantly reduced the rates of permanent facial paralysis in parotid surgery.

• Aesthetic Focus: Modern incisions ensure that surgical scars are nearly invisible once fully healed.

• Advanced Reconstruction: If the nerve must be removed, "cable grafting" techniques can often restore facial movement over 6–12 months.

• Targeted Adjuvant Therapy: Following surgery with precision radiation ensures that any microscopic cells near the facial nerve are eliminated.

• Multidisciplinary Excellence: Combining the skills of head and neck surgeons with reconstructive experts provides the best balance of cancer clearance and functional preservation.

A neck dissection is a major surgery to remove lymph nodes from the neck when cancer from the head, neck, or thyroid has spread (metastasized) or is at high risk of doing so. The goal is to clear the "drainage pathways" for cancer cells and provide a comprehensive pathology report for staging the disease. Surgical techniques prioritize the preservation of vital nerves and muscles to ensure better functional recovery.

• Node-Positive (N+): When scans (PET-CT/MRI) or a physical exam show clinically visible or palpable cancer in the lymph nodes.

• Elective/Prophylactic Surgery: When there is a greater than 15–20% risk of "hidden" (occult) metastasis, even if the neck appears clear on initial scans.

• Salvage Surgery: To address recurrent disease in the neck after previous radiation or chemotherapy treatments have failed.

• Primary Cancer Management: Often performed concurrently with the removal of the primary tumor (e.g., glossectomy or thyroidectomy) to ensure regional control.

• Unknown Primary: When a cancerous lymph node is found in the neck, but the original source of the cancer has not yet been identified.

• Selective Neck Dissection (SND): The most common approach; removes only the specific lymph node groups (e.g., Levels I–III or II–IV) most likely to harbor cancer based on the tumor's location.

• Modified Radical Neck Dissection (MRND): Removes lymph nodes from Levels I–V but spares one or more key structures (muscle, vein, or nerve) to preserve neck and shoulder function.

• Radical Neck Dissection (RND): Removes all lymph nodes (Levels I–V) on one side, along with the sternocleidomastoid muscle (SCM), internal jugular vein (IJV), and spinal accessory nerve (SAN).

• Extended Neck Dissection: Involves removing additional lymph node groups (like Level VI/central or retropharyngeal nodes) or extra structures like the carotid artery.

• Anesthesia: Performed under general anesthesia. Surgeons often use specialized nerve monitors to identify and protect motor nerves during the procedure.

• Incision: Often a single incision placed within a natural neck skin crease ("apron incision") to minimize visible scarring.

• Systematic Clearance: The surgeon carefully dissects the fatty tissue containing the lymph nodes away from the carotid artery, jugular vein, and the nerves that control the tongue and shoulder.

• Nerve Monitoring: Real-time monitoring of the Spinal Accessory Nerve (which moves the shoulder) and the Marginal Mandibular Nerve (which moves the lower lip) is a clinical standard.

• Drain Placement: One or more suction drains are placed under the skin to prevent fluid (seroma) or blood (hematoma) from collecting while the area heals.

• Pathology Processing: Each level of lymph nodes is labeled and sent separately to the lab to determine exactly how far the cancer has spread.

• Shoulder Mobility Assessment: Establishing a baseline for shoulder strength and range of motion to track progress during post-operative physical therapy.

• Imaging Correlation: Reviewing 3D reconstructions of CT or MRI scans to identify the proximity of enlarged nodes to the internal jugular vein.

• Tobacco Cessation: Stopping smoking at least 4 weeks prior is essential to prevent "skin flap necrosis," where the skin of the neck fails to heal properly.

• Medication Audit: Pausing any blood thinners or herbal supplements (like Ginkgo or Vitamin E) that could increase the risk of bleeding around major neck vessels.

• Nutritional Optimization: Ensuring adequate protein intake to support the healing of the large surgical surface area created during the dissection.

• Contrast-Enhanced CT or MRI: To map the "N-stage" of the cancer and identify any nodes that are "matted" or involving major veins.

• PET-CT Scan: To rule out distant spread to the lungs or liver, ensuring the neck surgery is part of a curative plan.

• Ultrasound-Guided FNAC: A fine-needle biopsy of suspicious nodes to confirm the presence of squamous cell carcinoma or thyroid cancer cells.

• Thyroid Profile: If the dissection involves Level VI (central neck), baseline calcium and PTH levels are checked to monitor parathyroid function.

• Coagulation Profile: A standard check (PT/INR) to ensure safe surgical hemostasis during the dissection of the "great vessels" of the neck.

• Hospital Stay: Expect to remain in the hospital for 2 to 5 days until the surgical drains are ready to be removed.

• Shoulder Weakness: If the spinal accessory nerve was handled or removed, you may experience "shoulder drop" or difficulty lifting your arm; physical therapy is vital.

• Nerve Weakness: Potential temporary or permanent weakness in the lower lip (marginal mandibular nerve) or tongue (hypoglossal nerve).

• Chyle Leak: A rare (1–2.5%) complication where a lymphatic channel is damaged, causing milky fluid to drain; this usually requires a special low-fat diet.

• Numbness: Permanent or temporary numbness in the neck, earlobe, or jawline is common because small sensory nerves are often divided.

• Activity Rules: Avoid heavy lifting (over 4.5kg) for 4 to 6 weeks to prevent strain on the healing neck tissues.

• Definitive Regional Control: Neck dissection is the most reliable way to remove microscopic cancer that imaging might miss, significantly reducing the risk of recurrence.

• Accurate Staging: The pathology report from the dissection determines whether you will need additional "adjuvant" radiation or chemotherapy.

• Functional Preservation: "Selective" techniques allow surgeons to remove the cancer while leaving the muscles and nerves intact for a better quality of life.

• Integrated Care: Modern surgical protocols focus on early movement and specialized physical therapy to prevent long-term neck stiffness.

• Lymphedema Management: Specialized therapy programs help manage any facial or neck swelling through manual lymphatic drainage and compression.